Trial Profile
Clinical Study on Fixed Dose Combination of S-amlodipine besylate and Clopidogrel bisulphate Tablet.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel/levamlodipine (Primary)
- Indications Hypertension; Ischaemic heart disorders; Peripheral vascular disorders; Stroke; Thrombosis
- Focus Therapeutic Use
- Sponsors Emcure Pharmaceuticals
- 24 Aug 2016 Status changed from active, no longer recruiting to completed.
- 07 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
- 08 Dec 2010 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.